Ursula M. Schmidt-Erfurth
Retina Department
University Eye Hospital
Lübeck
Germany
Name/email consistency: high
- Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Schmidt-Erfurth, U.M., Michels, S. Ophthalmology (2003)
- Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Schmidt-Erfurth, U., Schlötzer-Schrehard, U., Cursiefen, C., Michels, S., Beckendorf, A., Naumann, G.O. Invest. Ophthalmol. Vis. Sci. (2003)
- Photodynamic effects on choroidal neovascularization and physiological choroid. Schmidt-Erfurth, U., Michels, S., Barbazetto, I., Laqua, H. Invest. Ophthalmol. Vis. Sci. (2002)
- Histopathological changes following photodynamic therapy in human eyes. Schmidt-Erfurth, U., Laqua, H., Schlötzer-Schrehard, U., Viestenz, A., Naumann, G.O. Arch. Ophthalmol. (2002)
- Three-dimensional topographic angiography in chorioretinal vascular disease. Schmidt-Erfurth, U., Teschner, S., Noack, J., Birngruber, R. Invest. Ophthalmol. Vis. Sci. (2001)
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Schmidt-Erfurth, U., Miller, J.W., Sickenberg, M., Laqua, H., Barbazetto, I., Gragoudas, E.S., Zografos, L., Piguet, B., Pournaras, C.J., Donati, G., Lane, A.M., Birngruber, R., van den Berg, H., Strong, H.A., Manjuris, U., Gray, T., Fsadni, M., Bressler, N.M. Arch. Ophthalmol. (1999)